163 related articles for article (PubMed ID: 26711642)
1. Evolution of a Lung-Sparing Strategy with Sleeve Lobectomy and Induction Therapy for Non-small Cell Lung Cancer: 20-Year Experience at a Single Institution.
Tagawa T; Iwata T; Nakajima T; Suzuki H; Yoshida S; Yoshino I
World J Surg; 2016 Apr; 40(4):906-12. PubMed ID: 26711642
[TBL] [Abstract][Full Text] [Related]
2. Sleeve lobectomy compared with pneumonectomy after induction therapy for non-small-cell lung cancer.
Maurizi G; D'Andrilli A; Anile M; Ciccone AM; Ibrahim M; Venuta F; Rendina EA
J Thorac Oncol; 2013 May; 8(5):637-43. PubMed ID: 23584296
[TBL] [Abstract][Full Text] [Related]
3. Sleeve lobectomy as an alternative procedure to pneumonectomy for non-small cell lung cancer.
Park JS; Yang HC; Kim HK; Kim K; Shim YM; Choi YS; Kim J
J Thorac Oncol; 2010 Apr; 5(4):517-20. PubMed ID: 20104190
[TBL] [Abstract][Full Text] [Related]
4. Induction chemoradiotherapy followed by surgical resection for clinical T3 or T4 locally advanced non-small cell lung cancer.
Shien K; Toyooka S; Kiura K; Matsuo K; Soh J; Yamane M; Oto T; Takemoto M; Date H; Miyoshi S
Ann Surg Oncol; 2012 Aug; 19(8):2685-92. PubMed ID: 22396006
[TBL] [Abstract][Full Text] [Related]
5. Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
Santarpia M; Ramirez JL; de Aguirre I; Garrido P; Pérez Cano M; Queralt C; Gonzalez-Larriba JL; Insa A; Provencio M; Isla D; Camps C; Blanco R; Moran T; Rosell R;
Clin Lung Cancer; 2017 Mar; 18(2):178-188.e4. PubMed ID: 27908619
[TBL] [Abstract][Full Text] [Related]
6. Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy: incidence and outcomes.
Phernambucq EC; Hartemink KJ; Smit EF; Paul MA; Postmus PE; Comans EF; Senan S
J Thorac Oncol; 2012 Aug; 7(8):1271-5. PubMed ID: 22659960
[TBL] [Abstract][Full Text] [Related]
7. Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer: trends over time and 20-year institutional experience.
Takeda S; Maeda H; Koma M; Matsubara Y; Sawabata N; Inoue M; Tokunaga T; Ohta M
Eur J Cardiothorac Surg; 2006 Mar; 29(3):276-80. PubMed ID: 16434204
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase II trial of cisplatin, etoposide, and radiation followed by gemcitabine alone or by combined gemcitabine and docetaxel in stage III A/B unresectable non-small cell lung cancer.
Movsas B; Langer CJ; Ross HJ; Wang L; Jotte RM; Feigenberg S; Xu F; Huang CH; Monberg MJ; Obasaju CK
J Thorac Oncol; 2010 May; 5(5):673-9. PubMed ID: 20354453
[TBL] [Abstract][Full Text] [Related]
9. Is sleeve lobectomy comparable in terms of short- and long-term results with pneumonectomy after induction therapy? A multicenter analysis.
Cusumano G; Marra A; Lococo F; Margaritora S; Siciliani A; Maurizi G; Poggi C; Hillejan L; Rendina E; Granone P
Ann Thorac Surg; 2014 Sep; 98(3):975-83. PubMed ID: 25038013
[TBL] [Abstract][Full Text] [Related]
10. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
Hirsh V; Soulieres D; Duclos M; Faria S; Del Vecchio P; Ofiara L; Ayoub JP; Charpentier D; Gruber J; Portelance L; Souhami L
J Thorac Oncol; 2007 Oct; 2(10):927-32. PubMed ID: 17909355
[TBL] [Abstract][Full Text] [Related]
11. S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-small cell lung cancer: a pilot randomized controlled trial.
Yao L; Xu S; Xu J; Yang C; Wang J; Sun D
Radiat Oncol; 2015 Jan; 10():10. PubMed ID: 25572571
[TBL] [Abstract][Full Text] [Related]
12. Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study.
Takiguchi Y; Seto T; Ichinose Y; Nogami N; Shinkai T; Okamoto H; Minato K; Seki N; Eguchi K; Kishi K; Nishikawa M; Watanabe K
J Thorac Oncol; 2011 Jan; 6(1):156-60. PubMed ID: 21107293
[TBL] [Abstract][Full Text] [Related]
13. Is pneumonectomy after induction chemotherapy for non-small cell lung cancer a reasonable procedure? A multicenter retrospective study of 228 cases.
Thibout Y; Guibert B; Bossard N; Tronc F; Tiffet O; de la Roche E; Mulsant P; Gamondes JP; Baulieux J; Remontet L; Geriniere L; Souquet PJ
J Thorac Oncol; 2009 Dec; 4(12):1496-503. PubMed ID: 19745768
[TBL] [Abstract][Full Text] [Related]
14. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study: platinum-based induction chemotherapy combined with gemcitabine or paclitaxel for stage IIB-IIIA central non-small-cell lung cancer.
Lv C; Ma Y; Wu N; Yan S; Zheng Q; Sun Y; Li S; Fang J; Yang Y
World J Surg Oncol; 2013 Mar; 11():76. PubMed ID: 23517534
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility study.
Maruyama R; Hirai F; Ondo K; Kometani T; Hamatake M; Seto T; Sugio K; Ichinose Y
Surg Today; 2011 Nov; 41(11):1492-7. PubMed ID: 21969151
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine.
Collaud S; Waddell TK; Yasufuku K; Pierre AF; Darling GE; Cypel M; Rampersaud YR; Lewis SJ; Shepherd FA; Leighl NB; Cho J; Bezjak A; Tsao MS; Keshavjee S; de Perrot M
J Thorac Oncol; 2013 Dec; 8(12):1538-44. PubMed ID: 24389435
[TBL] [Abstract][Full Text] [Related]
18. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.
Kim YT; Kang CH; Sung SW; Kim JH
Ann Thorac Surg; 2005 Apr; 79(4):1153-61; discussion 1153-61. PubMed ID: 15797043
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of a phase II trial of induction paclitaxel-carboplatin followed by concurrent radiation therapy and weekly paclitaxel and consolidation paclitaxel-carboplatin in stage III non-small cell lung cancer.
Casas F; Viñolas N; Ferrer F; Agustí C; Sanchez M; Maria Gimferrer J; Lomeña F; Campayo M; Jeremic B
J Thorac Oncol; 2011 Jan; 6(1):79-85. PubMed ID: 21150466
[TBL] [Abstract][Full Text] [Related]
20. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]